Research
Search
Close
HAN Kun
- Graduate Supervisor, Associate Chief Physician
- Department: Oncology
- Research Area: Medical Technology
- Research Interests: Clinical and basic research of bone metastatic carcinoma
- Contact: doctor_hankun@163.com
- MPH from Shanghai Jiao Tong University School of Medicine, 2010
- Han K*, Lang T*, Zhang Z, Zhang Y, Sun Y, Shen Z, Beuerman RW, Zhou L#, Min D#. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics. Sci Rep. 2018 Jun 4;8(1):8537.
- Zhang, H, Han, K#. High intensity focused ultrasound enhances anti-tumor immunity through promoting CD4 Th1 effector T cell response. STEMedicine , 2020 Oct；1(4), e65.
- Jiang Z*, Han K*, Min D#, Kong W#, Wang S, Gao M. Identification of the methotrexate resistance-related diagnostic markers in osteosarcoma via adaptive total variation netNMF and multi-omics datasets. Front Genet. 2023 Oct 23;14:1288073.
- 01/01/2017-12/31/2019
National Natural Science Foundation of China , ¥200,000, 81703751
Molecular Pharmacology Mechanisms Study of Prostate Cancer Inhibition
Effect of Luteolin Through Wnt and Hippo Pathways
Role: Project leader - 01/01/2015-12/31/2017
Shanghai Municipal Science and Technology Commission , ¥100,000, 15ZR1432400
Molecular Mechanism of MPP8 Mediated Autophagy Effect in Osteosarcoma
Role: Project leader
